- CA$449.85m
- CA$457.79m
- CA$717.97m
- 78
- 54
- 69
- 74
2019 January 31st | 2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 740 | 720 | 649 | 819 | 718 |
Cost of Revenue | |||||
Gross Profit | 296 | 287 | 261 | 324 | 283 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 686 | 681 | 582 | 737 | 674 |
Operating Profit | 53.6 | 39.5 | 66.8 | 82.8 | 43.8 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 61 | 47.7 | 72.9 | 108 | 54 |
Provision for Income Taxes | |||||
Net Income After Taxes | 45.2 | 36 | 54.8 | 81.9 | 40.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 45.2 | 36 | 54.8 | 81.9 | 40.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 45.2 | 36 | 54.8 | 81.9 | 40.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.17 | 1.03 | 1.43 | 2.37 | 1.17 |
Dividends per Share |